331 related articles for article (PubMed ID: 19864235)
21. Pheochromocytoma-ganglioneuroma of the adrenal.
Kragel PJ; Johnston CA
Arch Pathol Lab Med; 1985 May; 109(5):470-2. PubMed ID: 3838664
[TBL] [Abstract][Full Text] [Related]
22. Detection of N-myc amplification in neuroblastomas using Southern blotting on fine needle aspirates.
Barroca H; Carvalho JL; da Costa MJ; Cirnes L; Seruca R; Schmitt FC
Acta Cytol; 2001; 45(2):169-72. PubMed ID: 11284301
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical analysis of N-myc protein expression in neuroblastoma: correlation with prognosis of patients.
Hiyama E; Hiyama K; Yokoyama T; Ishii T
J Pediatr Surg; 1991 Jul; 26(7):838-43. PubMed ID: 1895195
[TBL] [Abstract][Full Text] [Related]
24. Expression of the apoptosis-suppressing gene BCL-2 in pheochromocytoma is associated with the expression of C-MYC.
Wang DG; Johnston CF; Marley JJ; Phenix KV; Atkinson AB; Russell CF; Buchanan KD
J Clin Endocrinol Metab; 1997 Jun; 82(6):1949-52. PubMed ID: 9177412
[TBL] [Abstract][Full Text] [Related]
25. Sporadic type composite pheochromocytoma with neuroblastoma: clinicomorphologic, DNA content and ret gene analysis.
Candanedo-González FA; Alvarado-Cabrero I; Gamboa-Domínguez A; Cérbulo-Vázquez A; López-Romero R; Bornstein-Quevedo L; Salcedo-Vargas M
Endocr Pathol; 2001; 12(3):343-50. PubMed ID: 11740055
[TBL] [Abstract][Full Text] [Related]
26. [Role of immunohistochemical study of extracellular matrix components in the estimation of the malignant potential of adrenal pheochromocytomas].
Bezuglova TV; Poliakova GA; Kazantseva IA
Arkh Patol; 2008; 70(6):19-21. PubMed ID: 19227276
[TBL] [Abstract][Full Text] [Related]
27. Composite pheochromocytoma of the adrenal gland-a review of published cases.
Costa J; Jácome M; Souteiro P; Santos C; Cunha AL
Virchows Arch; 2023 Aug; 483(2):267-275. PubMed ID: 36645463
[TBL] [Abstract][Full Text] [Related]
28. Predictive factors for malignant pheochromocytoma: analysis of 136 patients.
Feng F; Zhu Y; Wang X; Wu Y; Zhou W; Jin X; Zhang R; Sun F; Kasoma Z; Shen Z
J Urol; 2011 May; 185(5):1583-90. PubMed ID: 21419457
[TBL] [Abstract][Full Text] [Related]
29. Ultrastructural pathology of adrenal medullary tumors.
Tannenbaum M
Pathol Annu; 1970; 5():145-71. PubMed ID: 4939997
[No Abstract] [Full Text] [Related]
30. [Molecular genetic abnormalities of N-myc and C-myc in pediatric neuroblastic tumors and clinical pathologic significance].
Cai RQ; Zhou CJ; Sun QN; Ma XL; Wang M; Li Y; Wang DY; Gong LP
Zhonghua Bing Li Xue Za Zhi; 2013 May; 42(5):299-304. PubMed ID: 24004585
[TBL] [Abstract][Full Text] [Related]
31. Case Report: Pheochromocytoma and Synchronous Neuroblastoma in a Family With Hereditary Pheochromocytoma Associated With a MAX Deleterious Variant.
Duarte DB; Ferreira L; Santos AP; Costa C; Lima J; Santos C; Afonso M; Teixeira MR; Carvalho R; Cardoso MH
Front Endocrinol (Lausanne); 2021; 12():609263. PubMed ID: 33815275
[TBL] [Abstract][Full Text] [Related]
32. Uptake of mIBG and catecholamines in noradrenaline- and organic cation transporter-expressing cells: potential use of corticosterone for a preferred uptake in neuroblastoma- and pheochromocytoma cells.
Bayer M; Kuçi Z; Schömig E; Gründemann D; Dittmann H; Handgretinger R; Bruchelt G
Nucl Med Biol; 2009 Apr; 36(3):287-94. PubMed ID: 19324274
[TBL] [Abstract][Full Text] [Related]
33. Composite phaeochromocytoma with malignant peripheral nerve sheath tumour and rhabdomyosarcomatous differentiation in a patient without von Recklinghausen disease.
Gupta R; Sharma A; Arora R; Vijayaraghavan M
J Clin Pathol; 2009 Jul; 62(7):659-61. PubMed ID: 19561238
[TBL] [Abstract][Full Text] [Related]
34. HuC/D expression in small round cell tumors and neuroendocrine tumors: a useful tool for distinguishing neuroblastoma from childhood small round cell tumors.
Takemoto J; Kuda M; Kohashi K; Yamada Y; Koga Y; Kinoshita I; Souzaki R; Taguchi T; Oda Y
Hum Pathol; 2019 Mar; 85():162-167. PubMed ID: 30468801
[TBL] [Abstract][Full Text] [Related]
35. [Molecular biology markers of neuroblastoma as the basis for a therapy concept].
Girgert R; Treuner J; Schweizer P
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():1053-5. PubMed ID: 9101780
[TBL] [Abstract][Full Text] [Related]
36. Characteristics of pheochromocytoma in a 4- to 20-year-old population.
Barontini M; Levin G; Sanso G
Ann N Y Acad Sci; 2006 Aug; 1073():30-7. PubMed ID: 17102069
[TBL] [Abstract][Full Text] [Related]
37. Composite adrenal anaplastic neuroblastoma and virilizing adrenocortical tumor with germline TP53 R248W mutation.
Rossbach HC; Baschinsky D; Wynn T; Obzut D; Sutcliffe M; Tebbi C
Pediatr Blood Cancer; 2008 Mar; 50(3):681-3. PubMed ID: 17427234
[TBL] [Abstract][Full Text] [Related]
38. Familial pheochromocytoma.
Bissada MA; Safwat AS; Seyam RM; Al Sobhi S; Hanash KA; Bissada NK
Urol Oncol; 2008; 26(4):361-3. PubMed ID: 18367101
[TBL] [Abstract][Full Text] [Related]
39. Malignant pheochromocytomas and paragangliomas: molecular signaling pathways and emerging therapies.
Santarpia L; Habra MA; Jiménez C
Horm Metab Res; 2009 Sep; 41(9):680-6. PubMed ID: 19343618
[TBL] [Abstract][Full Text] [Related]
40. Pheochromocytomas, PASS, and immunohistochemistry.
Carlsen E; Abdullah Z; Kazmi SM; Kousparos G
Horm Metab Res; 2009 Sep; 41(9):715-9. PubMed ID: 19718615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
